Wells Fargo & Company Atea Pharmaceuticals, Inc. Transaction History

Wells Fargo & Company

  • $410 Billion
  • Q1 2024

A detailed history of Wells Fargo & Company transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 27,539 shares of AVIR stock, worth $98,314. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,539
Previous 24,064 14.44%
Holding current value
$98,314
Previous $73,000 52.05%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
BUY
$3.09 - $4.56 $10,737 - $15,845
3,475 Added 14.44%
27,539 $111,000
Q4 2023

Feb 09, 2024
BUY
$2.8 - $3.35 $12,913 - $15,450
4,612 Added 23.71%
24,064 $73,000
Q3 2023

Nov 13, 2023
SELL
$3.0 - $3.79 $30,747 - $38,843
-10,249 Reduced 34.51%
19,452 $58,000
Q2 2023

Aug 15, 2023
BUY
$3.21 - $5.06 $50,194 - $79,123
15,637 Added 111.18%
29,701 $111,000
Q1 2023

May 12, 2023
BUY
$3.0 - $4.97 $40,692 - $67,413
13,564 Added 2712.8%
14,064 $47,000
Q4 2022

Feb 13, 2023
SELL
$4.35 - $6.17 $848 - $1,203
-195 Reduced 28.06%
500 $2,000
Q3 2022

Nov 14, 2022
SELL
$5.49 - $8.79 $3,414 - $5,467
-622 Reduced 47.23%
695 $4,000
Q2 2022

Aug 12, 2022
SELL
$5.33 - $8.18 $154,655 - $237,350
-29,016 Reduced 95.66%
1,317 $10,000
Q1 2022

May 16, 2022
SELL
$5.5 - $9.19 $117,865 - $196,941
-21,430 Reduced 41.4%
30,333 $219,000
Q4 2021

Feb 14, 2022
SELL
$7.67 - $44.59 $1.76 Million - $10.3 Million
-229,956 Reduced 81.63%
51,763 $463,000
Q3 2021

Nov 15, 2021
BUY
$21.33 - $35.06 $6 Million - $9.87 Million
281,441 Added 101237.77%
281,719 $9.88 Million
Q2 2021

Aug 16, 2021
SELL
$19.22 - $59.08 $82,415 - $253,335
-4,288 Reduced 93.91%
278 $6,000
Q1 2021

May 13, 2021
SELL
$41.42 - $88.44 $124,094 - $264,966
-2,996 Reduced 39.62%
4,566 $282,000
Q4 2020

Feb 09, 2021
BUY
$26.36 - $41.78 $199,334 - $315,940
7,562 New
7,562 $316,000

Others Institutions Holding AVIR

# of Institutions
120
Shares Held
49.6M
Call Options Held
108K
Put Options Held
327K
View Full List

About Atea Pharmaceuticals, Inc.

AVIR Quotes by TradingView
  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $297M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email